ADAG 주가 차트
ADAG 주가 예측
Adagene Inc
$4.23
16.2%
$0.59
종가: Aug 05, 16:00:00 GMT-4
$4.07
-3.64%
$-0.15
애프터마켓: Aug 05, 20:37:30 GMT-4
뒤로
Adagene Inc (ADAG) 주가 예측
주요 통계
이전 종가
$3.64
시가
$3.82
일일 범위
$3.65 - $4.24
52주 범위
$1.3 - $4.85
거래량
434.0K
평균 거래량
271.9K
배당수익률
--
EPS(TTM)
-0.30
시가총액
$269.3M
ADAG란 무엇인가요?
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. The firm is principally engaged in the research, development and production of monoclonal antibody drugs for cancers. The Company’s main products include: ADG106 is being developed for the treatment of advanced solid tumors and non-Hodgkin's lymphoma, or NHL. ADG126 is designed to address the toxicity and efficacy issues related to the MOA of existing approved CTLA-4 immuno-oncology therapies and to expand the potential of CTLA-4 as a target for the treatment of cancer. ADG116 is designed to target a unique conserved epitope of CTLA-4. And ADG104, a monospecific antibody that targets PD-L1 and is in Phase Ib and Phase II clinical trials concurrently in China.
